We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

52-Week Range
Valuation
Financials (FY2023-24)
Investment Thesis
Maverick Simulation Solutions Limited is a niche technology company at the cutting edge of India's medical and defence simulation sector, registered in Rajasthan. Its high unlisted share price of ₹2,030 reflects substantial investor confidence in a company operating in two high-priority national sectors. While the business case is strong thematically, the absence of public financial data, CIN, and ISIN necessitates thorough due diligence. This is a high-risk, high-reward opportunity best suited for sophisticated investors with access to private company disclosures.
Pros
Cons
Business Segments
Medical Simulation Solutions
Supply and support of medical simulation equipment and solutions for hospitals, medical colleges, nursing institutions, and skilling centres; India's #1 medical simulation company.
Engineering Simulation Solutions
Simulation technology for engineering education and industrial training applications.
Revenue Model
Maverick Simulation Solutions Limited generates revenue through the sale of simulation hardware and software systems to medical institutions (AIIMS, medical colleges, hospitals) and defence establishments (Army, Navy, Air Force, paramilitary forces). Revenue streams include equipment sales, annual maintenance contracts (AMCs), software licensing, and training service fees. Government procurement contracts (GeM portal, defence tenders) likely form the backbone of revenue.
Detailed Analysis
Growth Plans
NMC mandates for simulation-based training in medical colleges expanding domestic market
India's defence indigenisation push (Atmanirbhar Bharat) favouring domestic simulation equipment suppliers
Potential IPO listing that could significantly enhance liquidity and valuation discovery
Growing export opportunities for Indian-made simulation systems to emerging market healthcare systems
Recent Developments
Share price of ₹2,030 in the unlisted market suggests strong investor interest, potentially linked to anticipated IPO plans or strong recent financial performance.
2024-03National Medical Commission (NMC) mandates for simulation-based training in MBBS curriculum have expanded the addressable market for medical simulation companies in India.
2023-09Comparable Companies
ZENTEC · ₹5,000 Cr (listed)
BEL · ₹1,50,000 Cr (listed)
Frequently Asked Questions
About Maverick Simulation Solutions
Maverick Simulation Solutions Limited is an Indian technology company specialising in simulation solutions, likely serving defence, aerospace, training, or industrial simulation markets. Simulation technology companies provide virtual training environments, digital twin solutions, and modelling platforms that replicate real-world operational scenarios. In the Indian context, simulation solutions companies are increasingly important to the defence sector — the Ministry of Defence has been investing heavily in indigenous simulation training systems under the Make in India initiative, reducing dependence on foreign OEMs. Companies in this space develop flight simulators, tactical battlefield training systems, naval simulators, and industrial process simulations. Maverick's positioning in the simulation space suggests it may serve defence training establishments, civil aviation training centres, or industrial clients needing process simulation. The simulation technology market in India is growing rapidly given increased defence spending and the push for domestic solutions under Aatmanirbhar Bharat. Limited public data is available for Maverick Simulation Solutions Limited. Specific revenue figures, employee counts, and financial performance metrics are not available in public databases. The company operates as a specialised technology entity.
Key Milestones
Brand established 2006 as Maveric Solution Inc.; public company incorporated September 3, 2023 (CIN: U47721DL2023PLC419501)
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Increased Indian defence budget allocations driving procurement of training simulation systems
Industry Tailwinds
NMC mandates for simulation-based training in medical colleges expanding domestic market
India's defence indigenisation push (Atmanirbhar Bharat) favouring domestic simulation equipment suppliers
Potential IPO listing that could significantly enhance liquidity and valuation discovery
Growing export opportunities for Indian-made simulation systems to emerging market healthcare systems
Increased Indian defence budget allocations driving procurement of training simulation systems
Industry Headwinds
Government procurement delays and L1 bidding norms compressing margins
International competition from technologically superior global simulation companies
High valuation at ₹2,030 per share with limited price discovery mechanism in unlisted market
Significant portion of revenue likely depends on government tenders (medical colleges, defence), which are subject to policy changes, budget cuts, and L1 (lowest bidder) procurement practices.
Source: Company Financial Filings
Rapid advances in VR/AR simulation technology globally require continuous R&D investment; failure to keep pace could erode competitive advantage.
Source: AlphaHub Research
At ₹2,030/share in the unlisted market, valuation may be stretched relative to verifiable revenues; limited liquidity in unlisted shares amplifies this risk.
Source: Company Financial Filings
International simulation companies with large R&D budgets and established brand recognition compete for Indian government contracts, often with technology advantages.
Source: Media Reports / Public Records
If revenue is concentrated among a few large government contracts, loss of any major client could significantly impact financials.
Source: Company Financial Filings
Significant portion of revenue likely depends on government tenders (medical colleges, defence), which are subject to policy changes, budget cuts, and L1 (lowest bidder) procurement practices.
Rapid advances in VR/AR simulation technology globally require continuous R&D investment; failure to keep pace could erode competitive advantage.
At ₹2,030/share in the unlisted market, valuation may be stretched relative to verifiable revenues; limited liquidity in unlisted shares amplifies this risk.
International simulation companies with large R&D budgets and established brand recognition compete for Indian government contracts, often with technology advantages.
If revenue is concentrated among a few large government contracts, loss of any major client could significantly impact financials.
India's #1 medical simulation company; revenue ₹70.7 Cr (FY24); 29 employees; website: mavericksimulation.com
Registered at P.No-1 TF, Sector-12-B, Dwarka, South West Delhi 110075
Be the first to discuss Maverick Simulation Solutions — share your research, ask questions, or compare notes with other investors.